E. Williamson

First name
E.
Last name
Williamson
Sinnott, S. J., Smeeth, L., Williamson, E., Perel, P., Nitsch, D., Tomlinson, L. A., & Douglas, I. J. (2019). The comparative effectiveness of fourth-line drugs in resistant hypertension: An application in electronic health record data. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4808
Hopkins, C., Williamson, E., Morris, S., Clarke, C. S., Thomas, M., Evans, H., et al. (2019). Antibiotic usage in chronic rhinosinusitis: analysis of national primary care electronic health records. Rhinology. http://doi.org/10.4193/Rhin19.136
Wing, K., Williamson, E., Carpenter, J. R., Wise, L., Schneeweiss, S., Smeeth, L., et al. (2020). Real world effects of COPD medications: a cohort study with validation against RCT results. Eur Respir J. http://doi.org/10.1183/13993003.01586-2020
Tazare, J., Smeeth, L., Evans, S. J. W., Williamson, E., & Douglas, I. J. (2020). Implementing high-dimensional propensity score principles to improve confounder adjustment in UK electronic health records. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5121
Wilkinson, S., Williamson, E., Pokrajac, A., Fogarty, D., Stirnadel-Farrant, H., Smeeth, L., et al. (2020). Comparative effects of sulfonylureas, DPP4is and SGLT2 inhibitors added to metformin monotherapy: a propensity-score matched cohort study in UK primary care. Diabetes Obes Metab. http://doi.org/10.1111/dom.13970
Wing, K., Williamson, E., Carpenter, J. R., Wise, L., Schneeweiss, S., Smeeth, L., et al. (2021). Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results. Health Technol Assess. http://doi.org/10.3310/hta25510
Brown, J. P., Tazare, J. R., Williamson, E., Mansfield, K. E., Evans, S. J., Tomlinson, L. A., et al. (2021). Proton pump inhibitors and risk of all-cause and cause-specific mortality: a cohort study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.14728